Guardant Health Inc.

GH | NASDAQ

Price Alert Chart Builder DCF Calculator

$178.80

-$6.51 (-3.51%)

At close: Oct 30, 2026, 4:00 PM ET

$172.25

-$6.55 (-3.66%)

Pre-market: Nov 2, 2026, 8:12 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $23.99B

Enterprise Value $24.64B

Beta 1.58

Average Volume 2.25M

Shares Outstanding (Diluted) 132.07M

Shares Change YoY 6.41%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US40131M1099

Price Performance

Price Change 1M 0.3%

Price Change 3M 10.4%

Price Change 6M 104.1%

Price Change YTD 75.0%

Price Change 1Y 92.2%

Price Change 3Y 590.9%

Price Change 5Y 53.1%

1M CAGR (ann.) -0.3%

1Y CAGR (ann.) 147.4%

5Y CAGR (ann.) 10.3%

All-Time CAGR 23.6%

Valuation

PE Ratio -51.23

Forward PE N/A

PEG Ratio 11.61

Forward PEG -9.65

PS Ratio 20.28

Forward PS 13.10

PB Ratio -107.66

P/FCF Ratio -99.68

P/Adj. FCF Ratio -55.54

P/OCF Ratio -127.71

EV/Sales 20.82

EV/EBIT -54.79

EV/EBITDA -59.92

EV/FCF -102.35

Earnings Yield -1.9%

FCF Yield -1.0%

Adj. FCF Yield -1.8%

Financial Health

Net Debt $449.47M

Total Debt $1.7B

Cash & Short-Term Investments $1.05B

Total Assets $1.91B

Current Ratio 4.03

Quick Ratio 3.71

Debt / Equity Ratio -7.61

Debt / EBITDA -4.13

Debt / FCF -7.05

OCF / Debt -0.11

Interest Coverage -97.65

Altman Z-Score 4.87

Piotroski F-Score 5

Margins & Profitability

Gross Profit Margin 65.0%

Operating Profit Margin -39.8%

EBITDA Margin -34.8%

Net Profit Margin -38.3%

FCF Margin -20.4%

Adj. FCF Margin -36.5%

SBC / Revenue 16.2%

SBC Impact (per share) -79.5%

Returns

Return on Assets -23.7%

Return on Equity 211.5%

Return on Invested Capital -29.3%

Return on Capital Employed -29.9%

Return on Tangible Assets -25.1%

Historical Growth (CAGR)

Revenue CAGR 3Y 32.4%

Revenue CAGR 5Y 29.6%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 8.2%

EPS CAGR 5Y 12.7%

EPS CAGR 10Y N/A

FCF CAGR 3Y 10.8%

FCF CAGR 5Y 11.4%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 20

EPS Growth Next 3Y 41.7%

Revenue Growth Next 3Y 37.9%

Earnings Date Nov 5, 2026

EPS Estimate (next Q) -$0.75

EPS Growth Est (next Q) 1.4%

Revenue Est (next Q) $350.72M

Revenue Growth Est (next Q) 32.3%

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $203.40

Price Target Upside 13.8%

Cash Flow

Operating Cash Flow $-185.19M

Free Cash Flow $-240.72M

Adj. Free Cash Flow $-432.06M

FCF Per Share -$1.82

OCF Per Share -$1.40

OCF/S Ratio -15.7%

Income Statement

Revenue $1.18B

Gross Profit $769.16M

Operating Income $-470.26M

EBITDA $-411.19M

Net Income $-453.44M

EPS (Diluted) -$3.49

Revenue / Employee $473.62K

Profit / Employee $-181.52K

Employees 2,498